The DOI matches its Crossref record; 312 of the 312 references it cites were found in a registry or an index.
Potassium channel blockers in multiple sclerosis: Neuronal Kv channels and effects of symptomatic treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–312 of 312
Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels.
Kirsch, G. E., & Drewe, J. (1993) · The Journal of General Physiology · doi:10.1085/jgp.102.5.797 · Cited by 112
Morphological characteristics of central demyelination and remyelination: A single‐fiber study
Gledhill, R. F., & McDonald, W. I. (1977) · Annals of Neurology · doi:10.1002/ana.410010607 · Cited by 112
Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials
Bostock, H., Sherratt, R. M., & Sears, T. A. (1978) · Nature · doi:10.1038/274385a0 · Cited by 111
K+ channel distribution and clustering in developing and hypomyelinated axons of the optic nerve
Rasband, M. N., Trimmer, J. S., Peles, E., Levinson, S. R., & Shrager, P. G. (1999) · Journal of Neurocytology · doi:10.1023/a:1007057512576 · Cited by 110
McCormack, K., Joiner, W. J., & Heinemann, S. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90273-9 · Cited by 110
Regulation of microglial behavior by ion channel activity
Eder, C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20476 · Cited by 110
Sodium and potassium channels in regenerating and developing mammalian myelinated nerves
Ritchie, J. M. (1982) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1982.0042 · Cited by 110
Genetic Dysmyelination Alters the Molecular Architecture of the Nodal Region
Arroyo, E. J., Xu, T., Grinspan, J. B., Lambert, S., Levinson, S. R., Brophy, P., Peles, E., & Scherer, S. S. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01726.2002 · Cited by 105
Pennington, M. W., Byrnes, M., Zaydenberg, I., Khaytin, I., de Chastonay, J., Krafte, D. S., HILL, R., Mahnir, V. M., Volberg, W. A., Gorczyca, W. P., et al. (1995) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1995.tb01068.x · Cited by 104
Absence of potassium conductance in central myelinated axons
Kocsis, J. D., & Waxman, S. G. (1980) · Nature · doi:10.1038/287348a0 · Cited by 103
Kirsch, G. E., Drewe, J. A., Hartmann, H. A., Taglialatela, M., Biasi, M. D., Brown, A. M., & Johot, R. H. (1992) · Neuron · doi:10.1016/0896-6273(92)90278-l · Cited by 103
White, J. A., McALPINE, P. J., Antonarakis, S. E., Cann, H. M., Eppig, J. T., Frazer, K. S., Frézal, J., Lancet, D., Nahmias, J. A., Pearson, P. L., et al. (1997) · Genomics · doi:10.1006/geno.1997.4979 · Cited by 102
Conkunitzin-S1 Is the First Member of a New Kunitz-type Neurotoxin Family
Bayrhuber, M., Vijayan, V., Ferber, M., Graf, R., Korukottu, J., Imperial, J. S., Garrett, J. E., Olivera, B. M., Terlau, H., Zweckstetter, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500064200 · Cited by 102
Effects of strychnine on the sodium conductance of the frog node of Ranvier.
Shapiro, B. I. (1977) · The Journal of General Physiology · doi:10.1085/jgp.69.6.915 · Cited by 101
Calcium- and voltage-activated potassium channels in human macrophages
Gallin, E. K. (1984) · Biophysical Journal · doi:10.1016/s0006-3495(84)84080-1 · Cited by 98
Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine
Mainero, C., Inghilleri, M., Pantano, P., Conte, A., Lenzi, A., Frasca, V., Bozzao, L., & Pozzilli, C. (2004) · Neurology · doi:10.1212/01.wnl.0000129263.14219.a8 · Cited by 94
Kálmán, K., Nguyen, A., Tseng-Crank, J., Dukes, I. D., Chandy, G., Hustad, C. M., Copeland, N. G., Jenkins, N. A., Mohrenweiser, H. W., Brandriff, B. F., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5851 · Cited by 94
Sheean, G. L. (1998) · Brain · doi:10.1093/brain/121.5.967 · Cited by 92
Hurst, R. S., Busch, A. E., Kavanaugh, M. P., Osborne, P. B., North, R. A., & Adelman, J. P. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15369-8 · Cited by 92
Immunopathogenesis of the multiple sclerosis lesion
Markovic‐Plese, S., & McFarland, H. F. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0028-4 · Cited by 90
Comparative Molecular Neurobiology
Pichon, Y. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7265-2 · Cited by 89
Nashmi, R., Jones, O. T., & Fehlings, M. G. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00926.x · Cited by 85
KV1.1 K+ Channels Identification in Human Breast Carcinoma Cells: Involvement in Cell Proliferation
Ouadid-Ahidouch, H., Chaussade, F., Roudbaraki, M., Slomianny, C., Dewailly, E., Delcourt, P., & Prevarskaya, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3790 · Cited by 85
Kerr, P. M., Clément‐Chomienne, O., Thorneloe, K. S., Chen, T. T., Ishii, K., Sontag, D., Walsh, M. P., & Cole, W. C. (2001) · Circulation Research · doi:10.1161/hh2301.100803 · Cited by 85
Ritchie, J. M. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195082937.003.0004 · Cited by 85
Baba, H., Akita, H., Ishibashi, T., Inoue, Y., Nakahira, K., & Ikenaka, K. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991215)58:6<752::aid-jnr3>3.0.co;2-d · Cited by 83
Physiological Basis of Conduction in Myelinated Nerve Fibers
Rogart, R. B., & Ritchie, J. M. (1977) · Springer eBooks · doi:10.1007/978-1-4615-7514-6_4 · Cited by 82
Savarin, P., Guenneugues, M., Gilquin, B., Lamthanh, H., Gasparini, S., Zinn‐Justin, S., & Ménèz, A. (1998) · Biochemistry · doi:10.1021/bi9730341 · Cited by 82
A Model for 4-Aminopyridine Action on K Channels: Similarities to Tetraethylammonium Ion Action
Armstrong, C. M., & Loboda, A. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75749-9 · Cited by 80
Multiple Sclerosis as a Neuronal Disease
Waxman, S. G. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.22 · Cited by 79
Aminopyridines for symptomatic treatment in multiple sclerosis
Solari, A., Uitdehaag, B. M. J., Giuliani, G., Pucci, E., & Taus, C. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001330 · Cited by 78
Subunit composition and novel localization of K+ channels in spinal cord
Rasband, M. N., & Trimmer, J. S. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000101)429:1<166::aid-cne13>3.0.co;2-y · Cited by 77
It's “juxta” potassium channel!
Rasband, M. N. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20073 · Cited by 76
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients
Bever, C. T., Anderson, P. A., Leslie, J. L., PANITCH, H. S., Dhib-Jalbut, S. S., Khan, O., Milo, R., Hebel, J. R., Conway, K. L., Katz, E., et al. (1996) · Neurology · doi:10.1212/wnl.47.6.1457 · Cited by 76
Self-citationCytokine-dependent K+ channel profile of microglia at immunologically defined functional states
Fischer, H., Eder, C., Hadding, U., & Heinemann, U. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00398-o · Cited by 76
Handbook of membrane channels : molecular and cellular physiology
Peracchia, C. (1994) · Cited by 75
Voltage‐gated K + channels of the mammalian brain
Rehm, H., & Tempel, B. L. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.2.2004663 · Cited by 75
Localization of the Voltage-Sensor Toxin Receptor on KvAP
Ruta, V., & MacKinnon, R. (2004) · Biochemistry · doi:10.1021/bi049463y · Cited by 74
(1992) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1992.0036 · Cited by 73
Shieh, C. C., & Kirsch, G. E. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80718-0 · Cited by 72
Clay, J. R. (2004) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2003.12.004 · Cited by 71
On the mechanism of 4‐aminopyridine action on the cloned mouse brain potassium channel mKv1.1.
Stephens, G. J., Garratt, J. C., Robertson, B., & Owen, D. G. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020183 · Cited by 69
Preliminary trial of 3,4‐diaminopyridine in patients with multiple sclerosis
Bever, C. T., Leslie, J. L., Camenga, D. L., PANITCH, H. S., & Johnson, K. P. (1990) · Annals of Neurology · doi:10.1002/ana.410270411 · Cited by 68
Self-citationMapping the Functional Anatomy of BgK on Kv1.1, Kv1.2, and Kv1.3
Alessandri‐Haber, N., Lecoq, A., Gasparini, S., Grangier, G., Jacquet, G., Harvey, A. L., de Medeiros, C. L. C., Rowan, E. G., Gola, M., Ménèz, A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35653 · Cited by 68
Acute demyelination disrupts the molecular organization of peripheral nervous system nodes
Arroyo, E. J., Sirkowski, E. E., Chitale, R. V., & Scherer, S. S. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20321 · Cited by 67
Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5.
Bouchard, R. A., & Fedida, D. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12140-x · Cited by 67
Immunotherapy of multiple sclerosis: Where are we? Where should we go?
Martinꝉ, R., Stürzebecher, C.-S., & McFarland, H. F. (2001) · Nature Immunology · doi:10.1038/ni0901-785 · Cited by 66
Pathology of demyelination and remyelination.
Ludwin, S. K. (1981) · PubMed · Cited by 66
Blair, T. A., Roberds, S. L., Tamkun, M. M., & Hartshorne, R. P. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81420-d · Cited by 65
Bentrop, D., Beyermann, M., Wissmann, R., & Fakler, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107118200 · Cited by 64
Demyelinating diseases. Basic and clinical electrophysiology.
Waxman, S. G., & Ritchie, J. M. (1981) · PubMed · Cited by 63
Polman, C. H., Bertelsmann, F. W., de Waal, R., van Diemen, H. A. M., Uitdehaag, B. M. J., Loenen, A. C. V., & Koetsier, J. C. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540230074016 · Cited by 58
Site of action and active form of aminopyridines in squid axon membranes.
Kirsch, G. E., & Narahashi, T. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21412-4 · Cited by 58
Judge, S. I. V., Lee, J. M., Bever, C. T., & Hoffman, P. M. (2006) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2004.09.0116 · Cited by 57
Self-citationFunctional role of the NH2-terminal cytoplasmic domain of a mammalian A-type K channel.
Tseng-Crank, J., Yao, J., Berman, M. F., & Tseng, G. (1993) · The Journal of General Physiology · doi:10.1085/jgp.102.6.1057 · Cited by 56
Models of the Structure and Voltage-Gating Mechanism of the Shaker K+ Channel
Durell, S. R., Shrivastava, I. H., & Guy, H. R. (2004) · Biophysical Journal · doi:10.1529/biophysj.104.040618 · Cited by 56
Bagdáany, M., Batista, C. V. F., Valdez‐Cruz, N. A., Somodi, S., de la Vega, R. C. R., Licea-Navarro, A. F., Varga, Z., Gáspár, R., Possani, L. D., & Panyi, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007187 · Cited by 56
Stichodactyla helianthus Peptide, a Pharmacological Tool for Studying Kv3.2 Channels
Yan, L., Herrington, J. B., Goldberg, E. M., Dulski, P. M., Bugianesi, R. M., Slaughter, R. S., Banerjee, P., Brochu, R. M., Priest, B. T., Kaczorowski, G. J., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011064 · Cited by 54
Voltage-clamp studies in axons: Macroscopic and single-channel currents
Vogel, W., & Schwarz, J. R. (1995) · doi:10.1093/acprof:oso/9780195082937.003.0013 · Cited by 54
Internodal specializations of myelinated axons in the central nervous system
Arroyo, E. J., Xu, T., Poliak, S., Watson, M. R., Peles, E., & Scherer, S. S. (2001) · Cell and Tissue Research · doi:10.1007/s004410100403 · Cited by 51
Voltage-gated ion channels in axons: Localization, function, and development
Waxman, S. G. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195082937.003.0011 · Cited by 51
Mast Cell Degranulating Peptide: A Multi-functional Neurotoxin
Ziai, M. R., Russek, S. J., Wang, H.-C., Beer, B., & Blume, A. J. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb06595.x · Cited by 50
Resolving the Gating Charge Movement Associated with Late Transitions in K Channel Activation
Loboda, A., & Armstrong, C. M. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75750-5 · Cited by 50
Wissmann, R., Bildl, W., Oliver, D., Beyermann, M., Kalbitzer, H. R., Bentrop, D., & Fakler, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210191200 · Cited by 49
Chagot, B., Escoubas, P., Villegas, E., Bernard, C., Ferrat, G., Corzo, G. A., Lazdunski, M., & Darbon, H. (2004) · Protein Science · doi:10.1110/ps.03584304 · Cited by 49
Gilquin, B., Braud, S., Eriksson, M. A. L., Roux, B., Bailey, T. D., Priest, B. T., García, M. L., Ménèz, A., & Gasparini, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413626200 · Cited by 48
Monovalent cations in biological systems
(1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90049-c · Cited by 48
Multiple Sclerosis As A Neuronal Disease
(2005) · Elsevier eBooks · doi:10.1016/b978-0-12-738761-1.x5000-7 · Cited by 46
Block by 4‐aminopyridine of a Kv1.2 delayed rectifier K+ current expressed in Xenopus oocytes.
Russell, S. N., Publicover, N. G., Hart, P. J., Carl, A., Hume, J. R., Sanders, K. M., & Horowitz, B. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020464 · Cited by 44
Talukder, G., & Harrison, N. L. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.73.1.73 · Cited by 44
Bardien, S., Wulff, H., Arieff, Z., Brink, P. A., Chandy, K. G., & Corfield, V. A. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200739 · Cited by 43
Werkman, T. R., Kawamura, T., Yokoyama, S., Higashida, H., & Rogawski, M. A. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90216-o · Cited by 42
Holland, E. (2005) · Civil War Book Review · Cited by 42
Yao, J., & Tseng, G. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80462-x · Cited by 41
Scorpion toxins: Tools for studying K+ channels
García, M. L., Hanner, M., & Kaczorowski, G. J. (1998) · Toxicon · doi:10.1016/s0041-0101(98)00157-3 · Cited by 41
Akhtar, S., Shamotienko, O. G., Papakosta, M., Ali, F., & Dolly, J. O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109698200 · Cited by 41
Gelband, C. H., Warth, J. D., Mason, H. S., et al. (1999) · Circulation Research · doi:10.1161/01.res.84.3.352 · Cited by 39
Brooke, R. E., Atkinson, L., Batten, T. F. C., Deuchars, S. A., & Deuchars, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.051 · Cited by 38
(1998) · doi:10.1093/oso/9780198523604.001.0001 · Cited by 36
Electrophysiological characterization of a new member of the RCK family of rat brain K+ channels
Kirsch, G. E., Drewe, J., Verma, S., Brown, A. M., & Joho, R. H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80082-e · Cited by 34
Olamendi‐Portugal, T., Somodi, S., Fernández, J. A., Zamudio, F. Z., Becerril, B., Varga, Z., Panyi, G., Gáspár, R., & Possani, L. D. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.06.001 · Cited by 34
Tenenholz, T. C., Klenk, K. C., Matteson, D. R., Blaustein, M. P., & Weber, D. J. (2000) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0035552 · Cited by 33
Pathology of the myelin sheath
Ludwin, S. K. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195082937.003.0022 · Cited by 33
Potassium ion channels : Molecular structure, function, and diseases
Kurachi, Y., Jan, L. Y., & Lazdunski, M. (1999) · Cited by 31
Robertson, B., & Owen, D. G. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13634.x · Cited by 31
Aminopyridines block an inactivating potassium current having slow recovery kinetics
Wagoner, P. K., & Oxford, G. S. (1990) · Biophysical Journal · doi:10.1016/s0006-3495(90)82493-0 · Cited by 31
Middleton, R. E., Sánchez, M., Linde, A.-R., Bugianesi, R. M., Dai, G., Felix, J. P., Koprak, S., Staruch, M. J., Bruguera, M., Cox, R., et al. (2003) · Biochemistry · doi:10.1021/bi035209e · Cited by 29
Blockade of HERG Channels Expressed in Xenopus laevis Oocytes by External Divalent Cations
Ho, W., Kim, I., Lee, C. O., Youm, J. B., Lee, S., & Earm, Y. E. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77355-8 · Cited by 29
Effects of strychnine on the potassium conductance of the frog node of Ranvier.
Shapiro, B. I. (1977) · The Journal of General Physiology · doi:10.1085/jgp.69.6.897 · Cited by 27
Mechanism of 4-aminopyridine block of the transient outward K-current in identified Helix neuron
Kiss, T., László, Z., & Szabadics, J. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03351-0 · Cited by 25
Lessons from studies of antigen-specific T cell responses in Multiple Sclerosis
Martinꝉ, R., Bielekova, B., Gran, B., & McFarland, H. F. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_26 · Cited by 25
The Conduction Properties of Demyelinated and Remyelinated Axons
Smith, K. J., & Waxman, S. G. (2005) · Elsevier eBooks · doi:10.1016/b978-012738761-1/50007-9 · Cited by 22
Sea anemone toxins as templates for the design of immunosuppressant drugs
Kem, W. R., Pennington, M. W., & Norton, R. S. (1999) · Perspectives in Drug Discovery and Design · doi:10.1023/a:1017071131670 · Cited by 21
Aminopyridine block of Kv1.1 potassium channels expressed in mammalian cells and Xenopus oocytes.
Castle, N. A., Fadous, S. R., Logothetis, D. E., & Wang, G. K. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10596-8 · Cited by 21
Impaired M‐Current and Neuronal Excitability
Okada, M., Wada, K., 鎌田, 晃., Murakami, T., Zhu, G., & Kaneko, S. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.9.9.x · Cited by 19
Intrastriatal dendrotoxin injection: Behavioral and neurochemical effects
Silveira, R., Siciliano, J. C., Abó, V., et al. (1988) · Toxicon · doi:10.1016/0041-0101(88)90199-7 · Cited by 18
SCORPION VENOM AND MULTIPLE SCLEROSIS
Breland, A. E., & Currier, R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90996-0 · Cited by 17
A Gastropod Toxin Selectively Slows Early Transitions in the Shaker K Channel's Activation Pathway
Sack, J. T., Aldrich, R. W., & Gilly, W. F. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200409047 · Cited by 17
Introduction: Molecular diversity of Ion Channels and Cell Function
Rudy, B. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11269.x · Cited by 16
Judge, S. I. V., Yeh, J. Z., Goolsby, J. E., Monteiro, M. J., & Bever, C. T. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.4.913 · Cited by 15
Self-citation4‐Aminopyridine: Use in Multiple Sclerosis
Bever, C. T. (1995) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1995.tb00286.x · Cited by 13
Self-citationDevaux, J. J., Beeton, C., Béraud, E., & Crest, M. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)71001-2 · Cited by 13
Molecular determinants of the hanatoxin binding in voltage‐gated K+‐channel drk1
Lou, K., Huang, P., Shiau, Y., & Shiau, Y. (2002) · Journal of Molecular Recognition · doi:10.1002/jmr.571 · Cited by 12
The Structure of Myelinated Axons in the CNS
Hildebrand, C., & Mohseni, S. (2005) · Elsevier eBooks · doi:10.1016/b978-012738761-1/50002-x · Cited by 10
Potassium Channel Organization of Myelinated and Demyelinated Axons
Rasband, M. N. (2005) · Elsevier eBooks · doi:10.1016/b978-012738761-1/50005-5 · Cited by 7
Chapter 2 The Impact of the Caenorhabditis elegans Genome Project on Potassium Channel Biology
(1999) · Current topics in membranes · doi:10.1016/s0070-2161(08)60918-1 · Cited by 7
Rasmusson, R. L., Zhang, Y., Campbell, D. L., Comer, M. B., Castellino, R. C., Liu, S., Morales, M. J., & Strauss, H. C. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1893-8_2 · Cited by 6
The Roles of Potassium and Calcium Channels in Physiology and Pathophysiology of Axons
Chiu, S. Y. (2005) · Elsevier eBooks · doi:10.1016/b978-012738761-1/50006-7 · Cited by 5
Inflammation and Axon Degeneration
Perry, V. H. (2005) · Elsevier eBooks · doi:10.1016/b978-012738761-1/50018-3 · Cited by 5
Bagust, J., Zhang, L., & Owen, D. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00944-x · Cited by 4
Properties of Xenopus Kv1.10 channels expressed in HEK293 cells
Fry, M., Maue, R. A., & Moody‐Corbett, F. (2004) · Journal of Neurobiology · doi:10.1002/neu.20024 · Cited by 4
Chapter 1 Studies of Voltage-Dependent and Inwardly Rectifying Potassium Channels
Jan, L. Y. (1999) · Current topics in membranes · doi:10.1016/s0070-2161(08)60917-x · Cited by 2
Cited by
Goodman, A. D., Brown, T. R., Krupp, L. B., Schapiro, R. T., Schwid, S. R., Cohen, R., Marinucci, L. N., & Blight, A. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60442-6 · Cited by 549
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
Goodman, A. D., Brown, T. R., Edwards, K. R., Krupp, L. B., Schapiro, R. T., Cohen, R., Marinucci, L. N., Blight, A. R., & on behalf of the MSF204 Investigators (2010) · Annals of Neurology · doi:10.1002/ana.22240 · Cited by 374
Molecular Determinants of BK Channel Functional Diversity and Functioning
Latorre, R., Castillo, K., Carrasquel-Ursulaez, W., Sepulveda, R. V., Gonzalez-Nilo, F., Gonzalez, C., & Alvarez, O. (2017) · Physiological Reviews · doi:10.1152/physrev.00001.2016 · Cited by 271
“6 (216) as well as some small-conductance SKCa channels (173).”
BackgroundPeripheral nerve injury and myelination: Potential therapeutic strategies
Modrak, M., Talukder, M. A. H., Gurgenashvili, K., Noble, M., & Elfar, J. C. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24538 · Cited by 266
The node of Ranvier in CNS pathology
Arancibia-Carcamo, I. L., & Attwell, D. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1305-z · Cited by 177
Metadata
- Authors
- Judge, S. I. V., & Bever, C. T.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 111
- Issue
- 1
- Pages
- 224-259
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2055127611
- Cited by
- 268
- References
- 312
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.